Market Cap 2.00B
Revenue (ttm) 45.56M
Net Income (ttm) -241.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -530.29%
Debt to Equity Ratio 0.00
Volume 1,362,500
Avg Vol 999,008
Day's Range N/A - N/A
Shares Out 109.82M
Stochastic %K 6%
Beta -0.01
Analysts Strong Sell
Price Target $43.62

Latest News on NAMS

NewAmsterdam Pharma: A Mispriced Bet On A Cholesterol Revolution

Feb 28, 2025, 10:48 AM EST - 4 weeks ago

NewAmsterdam Pharma: A Mispriced Bet On A Cholesterol Revolution


Top 3 Health Care Stocks That May Collapse This Quarter

Dec 11, 2024, 6:55 AM EST - 4 months ago

Top 3 Health Care Stocks That May Collapse This Quarter

ADPT FNA


Why Is NewAmsterdam Pharma Stock Trading Higher On Tuesday?

Dec 10, 2024, 11:14 AM EST - 4 months ago

Why Is NewAmsterdam Pharma Stock Trading Higher On Tuesday?


NewAmsterdam Pharma Announces 2024 Strategic Priorities

Jan 4, 2024, 8:00 AM EST - 1 year ago

NewAmsterdam Pharma Announces 2024 Strategic Priorities


Tessellate BIO Emerges from Stealth

Oct 17, 2023, 3:00 AM EDT - 1 year ago

Tessellate BIO Emerges from Stealth

REPL


NewAmsterdam Pharma: Best Cardiovascular Biotech In 2023

Aug 19, 2023, 1:10 PM EDT - 1 year ago

NewAmsterdam Pharma: Best Cardiovascular Biotech In 2023